{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:34:39Z","timestamp":1771475679013,"version":"3.50.1"},"reference-count":136,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2019.00006","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T04:35:53Z","timestamp":1548736553000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Intracellular Streptococcal Uptake and Persistence: A Potential Cause of Erysipelas Recurrence"],"prefix":"10.3389","volume":"6","author":[{"given":"Fatma","family":"Jendoubi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg Christoph","family":"Prinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/archderm.1989.01670180051004","article-title":"Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique","volume":"125","author":"Bernard","year":"1989","journal-title":"Arch Dermatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/clinids\/23.5.1091","article-title":"Erysipelas: clinical and bacteriologic spectrum and serological aspects","volume":"23","author":"Eriksson","year":"1996","journal-title":"Clin Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1086\/527388","article-title":"Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings","volume":"46","author":"Siljander","year":"2008","journal-title":"Clin Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MD.0b013e3181e8d635","article-title":"The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation","volume":"89","author":"Jeng","year":"2010","journal-title":"Medicine"},{"key":"B5","first-page":"723","article-title":"Impetigo, erysipelas and cellulitis","volume-title":"Streptococcus pyogenes: Basic Biology to Clinical Manifestations","author":"Stevens","year":"2016"},{"key":"B6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1056\/NEJM199601253340407","article-title":"Streptococcal infections of skin and soft tissues","volume":"334","author":"Bisno","year":"1996","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/00128071-200304030-00002","article-title":"Erysipelas: recognition and management","volume":"4","author":"Bonnetblanc","year":"2003","journal-title":"Am J Clin Dermatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.amjmed.2011.06.028","article-title":"Cellulitis: definition, etiology, and clinical features","volume":"124","author":"Gunderson","year":"2011","journal-title":"Am J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000104262","article-title":"Epidemiology and comorbidity of erysipelas in primary care","volume":"215","author":"Bartholomeeusen","year":"2007","journal-title":"Dermatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/j.1468-3083.2006.01657.x","article-title":"Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands","volume":"20","author":"Goettsch","year":"2006","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1017\/S095026880500484X","article-title":"Cellulitis incidence in a defined population","volume":"134","author":"Ellis Simonsen","year":"2006","journal-title":"Epidemiol Infect."},{"key":"B12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/jama.2016.8825","article-title":"Cellulitis: a review","volume":"316","author":"Raff","year":"2016","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1365-4362.1990.tb04833.x","article-title":"Erysipelas","volume":"29","author":"Chartier","year":"1990","journal-title":"Int J Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/0002-9378(92)91597-4","article-title":"Necrotizing fasciitis of the vulva","volume":"166","author":"Stephenson","year":"1992","journal-title":"Am J Obstetr Gynecol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"26.21","DOI":"10.1002\/9781118441213.rtd0026","article-title":"Bacterial infections","volume-title":"Rook's Textbook of Dermatology, 9th ed","author":"Hay","year":"2016"},{"key":"B16","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/B978-1-4557-4801-3.00095-3","article-title":"Cellulitis, necrotizing fasciitis and subcutaneous tissue infections","volume-title":"Mandell, Douglas, and Bennetts Principles and Practice of Infectious Diseases","author":"Pasternack","year":"2015"},{"key":"B17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1128\/CMR.13.3.470","article-title":"Pathogenesis of group a streptococcal infections","volume":"13","author":"Cunningham","year":"2000","journal-title":"Clin Microbiol Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1128\/CMR.00101-13","article-title":"Disease manifestations and pathogenic mechanisms of group a Streptococcus","volume":"27","author":"Walker","year":"2014","journal-title":"Clin Microbiol Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1001\/jama.2016.15613","article-title":"Therapy for cellulitis","volume":"316","author":"Raff","year":"2016","journal-title":"JAMA"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1086\/516375","article-title":"Why have group a streptococci remained susceptible to penicillin? Report on a symposium","volume":"26","author":"Horn","year":"1998","journal-title":"Clin Infect Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1089\/mdr.2015.0040","article-title":"Susceptibility of Group a streptococcus to antimicrobial agents in northern israel: a surveillance study","volume":"21","author":"Chazan","year":"2015","journal-title":"Microbial Drug Resistance"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of america","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa013169","article-title":"Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh","volume":"346","author":"Martin","year":"2002","journal-title":"N Engl. J Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/ppul.20976","article-title":"High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China","volume":"44","author":"Liu","year":"2009","journal-title":"Pediatr Pulmonol."},{"key":"B25","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/JCM.37.6.1727-1731.1999","article-title":"Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California","volume":"37","author":"York","year":"1999","journal-title":"J Clin Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1206300","article-title":"Penicillin to prevent recurrent leg cellulitis","volume":"368","author":"Thomas","year":"2013","journal-title":"N Engl J Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1056\/NEJMc1307321","article-title":"Penicillin to prevent recurrent leg cellulitis","volume":"369","author":"Arasaratnam","year":"2013","journal-title":"N Engl J Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/j.1365-2133.2008.08503.x","article-title":"Erysipelas as a sign of subclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg","volume":"158","author":"Damstra","year":"2008","journal-title":"Br J Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/j.1365-2133.2007.08423.x","article-title":"Lymphatic abnormalities demonstrated by lymphoscintigraphy after lower limb cellulitis","volume":"158","author":"Soo","year":"2008","journal-title":"Br J Dermatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/j.1365-2133.2011.10275.x","article-title":"Severe lower limb cellulitis is best diagnosed by dermatologists and managed with shared care between primary and secondary care","volume":"164","author":"Levell","year":"2011","journal-title":"Br J Dermatol."},{"key":"B31","first-page":"89","article-title":"Recurrent erysipelas despite antibiotic prophylaxis: an analysis from case studies","volume":"65","author":"Koster","year":"2007","journal-title":"Netherlands J Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/BF01728920","article-title":"Antibiotic prophylaxis in recurrent erysipelas","volume":"21","author":"Sjoblom","year":"1993","journal-title":"Infection"},{"key":"B33","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S0140-6736(85)91761-1","article-title":"Prophylactic antibiotics in recurrent erysipelas","volume":"1","author":"Thind","year":"1985","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1046\/j.1439-0353.2004.03028.x","article-title":"Recurrent erysipelas: risk factors","volume":"2","author":"Pavlotsky","year":"2004","journal-title":"J Deutschen Dermatol Gesellschaft"},{"key":"B35","doi-asserted-by":"publisher","first-page":"CD009758","DOI":"10.1002\/14651858.CD009758.pub2","article-title":"Interventions for the prevention of recurrent erysipelas and cellulitis","volume":"6","author":"Dalal","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000096913","article-title":"Recurrent erysipelas: 47 cases","volume":"214","author":"Leclerc","year":"2007","journal-title":"Dermatology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1136\/bmj.318.7198.1591","article-title":"Risk factors for erysipelas of the leg (cellulitis): case-control study","volume":"318","author":"Dupuy","year":"1999","journal-title":"BMJ"},{"key":"B38","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.1365-2133.2006.07419.x","article-title":"Oedema as a risk factor for multiple episodes of cellulitis\/erysipelas of the lower leg: a series with community follow-up","volume":"155","author":"Cox","year":"2006","journal-title":"Br J Dermatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/archinte.167.7.709","article-title":"A predictive model of recurrent lower extremity cellulitis in a population-based cohort","volume":"167","author":"McNamara","year":"2007","journal-title":"Arch Int Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF01650206","article-title":"Recurrent erysipelas: predisposing factors and costs of prophylaxis","volume":"15","author":"Jorup-Ronstrom","year":"1987","journal-title":"Infection"},{"key":"B41","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/00000441-200612000-00002","article-title":"Risk factors for recurrent lower extremity cellulitis in a U","volume":"332","author":"Lewis","year":"2006","journal-title":"Am J Med Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3109\/00365548609021656","article-title":"Epidemiological, bacteriological and complicating features of erysipelas","volume":"18","author":"Jorup-Ronstrom","year":"1986","journal-title":"Scand J Infect Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.1128\/IAI.71.9.5376-5380.2003","article-title":"Intracellular survival of Streptococcus pyogenes in polymorphonuclear cells results in increased bacterial virulence","volume":"71","author":"Medina","year":"2003","journal-title":"Infect Immun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1086\/373998","article-title":"Survival of Streptococcus pyogenes within host phagocytic cells: a pathogenic mechanism for persistence and systemic invasion","volume":"187","author":"Medina","year":"2003","journal-title":"J Infect Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/1471-2334-14-270","article-title":"Recurrent erysipelas\u2013risk factors and clinical presentation","volume":"14","author":"Inghammar","year":"2014","journal-title":"BMC Infect Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"448","DOI":"10.7861\/clinmedicine.4-5-448","article-title":"Chronic peripheral oedema: the critical role of the lymphatic system","volume":"4","author":"Mortimer","year":"2004","journal-title":"Clin Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/j.1365-2133.2008.08489.x","article-title":"Ethnicity and other risk factors for acute lower limb cellulitis: a U","volume":"158","author":"Halpern","year":"2008","journal-title":"Br J Dermatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1469-0691.2009.02906.x","article-title":"Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study","volume":"16","author":"Karppelin","year":"2010","journal-title":"Clin Microbiol Infect."},{"key":"B49","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/j.1365-2133.1997.tb01553.x","article-title":"Evidence for altered cell-mediated immunity in postmastectomy lymphoedema","volume":"137","author":"Mallon","year":"1997","journal-title":"Br J Dermatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/0002-9343(92)90583-W","article-title":"Cellulitis after axillary lymph node dissection for carcinoma of the breast","volume":"93","author":"Simon","year":"1992","journal-title":"Am J Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1475-2883-2-4","article-title":"Lymphoedema: pathophysiology and management in resource-poor settings - relevance for lymphatic filariasis control programmes","volume":"2","author":"Vaqas","year":"2003","journal-title":"Filaria J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1086\/497127","article-title":"Risk factors for acute cellulitis of the lower limb: a prospective case-control study","volume":"41","author":"Bjornsdottir","year":"2005","journal-title":"Clin Infect Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s11908-014-0422-0","article-title":"Recurrent cellulitis: risk factors, etiology, pathogenesis and treatment","volume":"16","author":"Chlebicki","year":"2014","journal-title":"Curr Infect Dis Rep."},{"key":"B54","first-page":"177","article-title":"Lymphoscintigraphic evaluation in patients after erysipelas","volume":"33","author":"de Godoy","year":"2000","journal-title":"Lymphology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/0090-8258(88)90146-1","article-title":"Recurrent acute leg cellulitis in patients after radical vulvectomy","volume":"29","author":"Bouma","year":"1988","journal-title":"Gynecol Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"493","DOI":"10.7326\/0003-4819-97-4-493","article-title":"Recurrent cellulitis after saphenous venectomy for coronary bypass surgery","volume":"97","author":"Baddour","year":"1982","journal-title":"Ann. Int Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/jama.1984.03340320035023","article-title":"Recurrent cellulitis after coronary bypass surgery","volume":"251","author":"Baddour","year":"1984","journal-title":"JAMA"},{"key":"B58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000090649","article-title":"Risk factors for erysipelas of the leg in Tunisia: a multicenter case-control study","volume":"212","author":"Mokni","year":"2006","journal-title":"Dermatology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000080853","article-title":"Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study","volume":"209","author":"Roujeau","year":"2004","journal-title":"Dermatology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/bjd.15186","article-title":"Risk factors for nonpurulent leg cellulitis: a systematic review and meta-analysis","volume":"177","author":"Quirke","year":"2017","journal-title":"Br J Dermatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0163-4453(91)90898-3","article-title":"Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections","volume":"22","author":"Kremer","year":"1991","journal-title":"J Infect."},{"key":"B62","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1469-0691.2005.01169.x","article-title":"Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects","volume":"11","author":"Ekelund","year":"2005","journal-title":"Clin Microb Infect."},{"key":"B63","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0002-9343(85)90003-8","article-title":"Non-group A beta-hemolytic streptococcal cellulitis","volume":"79","author":"Baddour","year":"1985","journal-title":"Am J Med."},{"key":"B64","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1128\/IAI.65.4.1357-1363.1997","article-title":"The fibronectin-binding protein of Streptococcus pyogenes, SfbI, is involved in the internalization of group A streptococci by epithelial cells","volume":"65","author":"Molinari","year":"1997","journal-title":"Infect Immun."},{"key":"B65","doi-asserted-by":"publisher","first-page":"12115","DOI":"10.1073\/pnas.91.25.12115","article-title":"Group A streptococci efficiently invade human respiratory epithelial cells","volume":"91","author":"LaPenta","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/S0140-6736(97)12452-7","article-title":"Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers","volume":"352","author":"Neeman","year":"1998","journal-title":"Lancet"},{"key":"B67","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3109\/00016489509139387","article-title":"Intracellular penetration and survival of Streptococcus pyogenes in respiratory epithelial cells in vitro","volume":"115","author":"Osterlund","year":"1995","journal-title":"Acta otolaryngol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3109\/00016489709114219","article-title":"An intracellular sanctuary for Streptococcus pyogenes in human tonsillar epithelium\u2013studies of asymptomatic carriers and in vitro cultured biopsies","volume":"117","author":"Osterlund","year":"1997","journal-title":"Acta otolaryngol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00005537-199705000-00016","article-title":"Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis","volume":"107","author":"Osterlund","year":"1997","journal-title":"Laryngoscope"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1086\/515310","article-title":"Invasion and survival of Streptococcus pyogenes in eukaryotic cells correlates with the source of the clinical isolates","volume":"177","author":"Molinari","year":"1998","journal-title":"J Infect Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1086\/515589","article-title":"Protein F1 is required for efficient entry of Streptococcus pyogenes into epithelial cells","volume":"178","author":"Jadoun","year":"1998","journal-title":"J Infect Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/978-1-4899-1825-3_121","article-title":"Proteins M6 and F1 are required for efficient invasion of group A streptococci into cultured epithelial cells","volume":"418","author":"Jadoun","year":"1997","journal-title":"Adv Exp Med Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1046\/j.1365-2958.1999.01223.x","article-title":"High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements","volume":"31","author":"Dombek","year":"1999","journal-title":"Mol Microbiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1099\/00222615-47-10-899","article-title":"Ability of clinical isolates of group A streptococci to adhere to and invade HEp-2 epithelial cells","volume":"47","author":"Bennett-Wood","year":"1998","journal-title":"J Med Microbiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1086\/523647","article-title":"The contribution of dendritic cells to host defenses against Streptococcus pyogenes","volume":"196","author":"Loof","year":"2007","journal-title":"J Infect Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(00)02765-3","article-title":"Pharyngeal carriage of group C and group G streptococci and acute rheumatic fever in an Aboriginal population","volume":"356","author":"Haidan","year":"2000","journal-title":"Lancet"},{"key":"B77","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.micinf.2011.10.008","article-title":"Molecular mechanisms of Streptococcus dysgalactiae subsp equisimilis enabling intravascular persistence","volume":"14","author":"Rohde","year":"2012","journal-title":"Microbes Infect."},{"key":"B78","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1046\/j.1365-2958.1998.01097.x","article-title":"Roles of integrins and fibronectin in the entry of Streptococcus pyogenes into cells via protein F1","volume":"30","author":"Ozeri","year":"1998","journal-title":"Mol Microbiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1172\/JCI118998","article-title":"Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection","volume":"98","author":"Schrager","year":"1996","journal-title":"J Clin Invest."},{"key":"B80","first-page":"547","article-title":"Adhesion and invasion of Streptococcus pyogenes into host cells and clinical relevance of intracellular streptococci","volume-title":"Streptococcus pyogenes: Basic Biology to Clinical Manifestations.","author":"Rohde","year":"2016"},{"key":"B81","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1046\/j.1462-5822.2000.00040.x","article-title":"Two distinct pathways for the invasion of Streptococcus pyogenes in non-phagocytic cells","volume":"2","author":"Molinari","year":"2000","journal-title":"Cell Microbiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1046\/j.1462-5822.2003.00279.x","article-title":"Host cell caveolae act as an entry-port for group A streptococci","volume":"5","author":"Rohde","year":"2003","journal-title":"Cell Microbiol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/07853890252953464","article-title":"Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci","volume":"34","author":"Courtney","year":"2002","journal-title":"Ann Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1160\/TH07-03-0179","article-title":"Invasion mechanisms of Gram-positive pathogenic cocci","volume":"98","author":"Nitsche-Schmitz","year":"2007","journal-title":"Thromb Haemost."},{"key":"B85","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1128\/MMBR.00014-09","article-title":"Streptococcus adherence and colonization","volume":"73","author":"Nobbs","year":"2009","journal-title":"Microbiol Mol Biol Rev."},{"key":"B86","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/82_2012_281","article-title":"Adherence and invasion of streptococci to eukaryotic cells and their role in disease pathogenesis","volume":"368","author":"Rohde","year":"2013","journal-title":"Curr. Topics Microbiol Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000081691","article-title":"Gram-positive adhesins","volume":"12","author":"Talay","year":"2005","journal-title":"Contribut Microbiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1462-5822.2010.01547.x","article-title":"Differences in the aromatic domain of homologous streptococcal fibronectin-binding proteins trigger different cell invasion mechanisms and survival rates","volume":"13","author":"Rohde","year":"2011","journal-title":"Cell Microbiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.chom.2013.11.003","article-title":"The globally disseminated M1T1 clone of group A Streptococcus evades autophagy for intracellular replication","volume":"14","author":"Barnett","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B90","doi-asserted-by":"publisher","first-page":"10948","DOI":"10.1073\/pnas.1833375100","article-title":"Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils","volume":"100","author":"Kobayashi","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"B91","doi-asserted-by":"publisher","first-page":"21612","DOI":"10.1074\/jbc.M110.202671","article-title":"Streptococcus pyogenes M49 plasminogen\/plasmin binding facilitates keratinocyte invasion via integrin-integrin-linked kinase (ILK) pathways and protects from macrophage killing","volume":"286","author":"Siemens","year":"2011","journal-title":"J Biol Chem."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1371\/journal.pmed.0030053","article-title":"Viable group A streptococci in macrophages during acute soft tissue infection","volume":"3","author":"Thulin","year":"2006","journal-title":"PLoS Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/j.1462-5822.2011.01610.x","article-title":"The FbaB-type fibronectin-binding protein of Streptococcus pyogenes promotes specific invasion into endothelial cells","volume":"13","author":"Amelung","year":"2011","journal-title":"Cell Microbiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/jama.1950.02910370001001","article-title":"Prevention of rheumatic fever; treatment of the preceding streptococcic infection","volume":"143","author":"Denny","year":"1950","journal-title":"J Am Med Assoc."},{"key":"B95","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1086\/340949","article-title":"Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis","volume":"35","author":"Bisno","year":"2002","journal-title":"Clin Infect Dis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/clinids\/14.1.2","article-title":"Invasive group A streptococcus infections","volume":"14","author":"Stevens","year":"1992","journal-title":"Clin Infect Dis."},{"key":"B97","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1542\/peds.40.2.188","article-title":"How well do patients take oral penicillin? A collaborative study in private practice","volume":"40","author":"Charney","year":"1967","journal-title":"Pediatrics"},{"key":"B98","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1097\/00006454-199110001-00011","article-title":"The rising incidence of penicillin treatment failures in group A streptococcal tonsillopharyngitis: an emerging role for the cephalosporins?","volume":"10","author":"Pichichero","year":"1991","journal-title":"Pediatr Infect Dis J."},{"key":"B99","first-page":"827","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS)","volume-title":"Streptococcus pyogenes: Basic Biology to Clinical Manifestations","author":"Orefici","year":"2016"},{"key":"B100","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1086\/318542","article-title":"Characterization of consecutive Streptococcus pyogenes isolates from patients with pharyngitis and bacteriological treatment failure: special reference to prtF1 and sic \/ drs","volume":"183","author":"Brandt","year":"2001","journal-title":"J Infect Dis."},{"key":"B101","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1099\/0022-1317-49-6-499","article-title":"Relationship between asymptomatic carriage of Streptococcus pyogenes and the ability of the strains to adhere to and be internalised by cultured epithelial cells","volume":"49","author":"Sela","year":"2000","journal-title":"J Med Microbiol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3109\/07853899908995895","article-title":"Why do we fail with penicillin in the treatment of group A streptococcus infections?","volume":"31","author":"Sela","year":"1999","journal-title":"Ann. Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1086\/508773","article-title":"Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications","volume":"43","author":"Kaplan","year":"2006","journal-title":"Clin Infect Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1001\/jama.1981.03320160022023","article-title":"Penicillin V for group A streptococcal pharyngotonsillitis","volume":"246","author":"Schwartz","year":"1981","journal-title":"JAMA"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD004299.pub2","article-title":"Interventions for cellulitis and erysipelas","volume":"6","author":"Kilburn","year":"2010","journal-title":"Cochrane Database Syst Rev."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/bjd.16235","article-title":"Which outcomes are reported in cellulitis trials? Results of a review of outcomes included in cellulitis trials and a patient priority setting survey","volume":"178","author":"Smith","year":"2017","journal-title":"Br J Dermatol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/QCO.0000000000000242","article-title":"Current guidelines and recommendations for the management of skin and soft tissue infections","volume":"29","author":"Montravers","year":"2016","journal-title":"Curr Opin Infect Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/QCO.0b013e32805dfb2d","article-title":"Acute bacterial skin infections and cellulitis","volume":"20","author":"Gabillot-Carre","year":"2007","journal-title":"Curr Opin Infect Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2165\/00003495-200161040-00008","article-title":"Linezolid: a review of its use in the management of serious gram-positive infections","volume":"61","author":"Perry","year":"2001","journal-title":"Drugs"},{"key":"B110","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/00045391-200307000-00006","article-title":"Comparison of linezolid with oxacillin or vancomycin in the empiric treatment of cellulitis in US hospitals","volume":"10","author":"Vinken","year":"2003","journal-title":"Am. J. Ther."},{"key":"B111","unstructured":"PichicheroME Treatment and prevention of streptococcal tonsillopharyngitis2017"},{"key":"B112","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1542\/pir.19-9-291","article-title":"Group A beta-hemolytic streptococcal infections","volume":"19","author":"Pichichero","year":"1998","journal-title":"Pediatr Rev."},{"key":"B113","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3109\/00365549409011811","article-title":"Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment","volume":"26","author":"Orrling","year":"1994","journal-title":"Scand J Infect Dis."},{"key":"B114","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0022-3476(05)81052-2","article-title":"Clindamycin treatment of chronic pharyngeal carriage of group A streptococci","volume":"119","author":"Tanz","year":"1991","journal-title":"J Pediatr."},{"key":"B115","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0022-3476(88)80291-9","article-title":"Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure","volume":"113","author":"Kaplan","year":"1988","journal-title":"J Pediatr."},{"key":"B116","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ijporl.2009.02.004","article-title":"Rate of eradication of group A beta-hemolytic streptococci in children with pharyngo-tonsillitis by amoxicillin and cefdinir","volume":"73","author":"Brook","year":"2009","journal-title":"Int J Pediatr Otorhinolaryngol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1542\/peds.113.4.866","article-title":"Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children","volume":"113","author":"Casey","year":"2004","journal-title":"Pediatrics"},{"key":"B118","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2165\/00128072-200204110-00006","article-title":"Antibacterial therapy for acute group a streptococcal pharyngotonsillitis: short-course versus traditional 10-day oral regimens","volume":"4","author":"Brook","year":"2002","journal-title":"Paediatr Drugs"},{"key":"B119","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0022-3476(86)80139-1","article-title":"Once daily therapy for streptococcal pharyngitis with cefadroxil","volume":"109","author":"Gerber","year":"1986","journal-title":"J Pediatr."},{"key":"B120","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/00006454-200001000-00009","article-title":"Impact of azithromycin on oropharyngeal carriage of group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae","volume":"19","author":"Morita","year":"2000","journal-title":"Pediatr Infect Dis J."},{"key":"B121","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/QCO.0b013e3283458f7e","article-title":"New understandings in Streptococcus pyogenes","volume":"24","author":"Lynskey","year":"2011","journal-title":"Curr Opin Infect Dis."},{"key":"B122","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/jpids\/piu030","article-title":"The group A streptococcal carrier state reviewed: still an enigma","volume":"3","author":"DeMuri","year":"2014","journal-title":"J Pediatr Infect Dis Soc."},{"key":"B123","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1128\/JCM.42.12.5620-5623.2004","article-title":"Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results","volume":"42","author":"Desjardins","year":"2004","journal-title":"J Clin Microbiol."},{"key":"B124","first-page":"587","article-title":"The Streptococcus pyogenes carrier state","volume-title":"Streptococcus pyogenes","author":"Martin","year":"2016"},{"key":"B125","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0022-3476(85)80687-9","article-title":"Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy","volume":"106","author":"Chaudhary","year":"1985","journal-title":"J Pediatr."},{"key":"B126","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1586\/14787210.2015.1023292","article-title":"Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies","volume":"13","author":"Silva-Costa","year":"2015","journal-title":"Expert Rev Anti-Infect Ther."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","article-title":"Improved outcome of clindamycin compared with beta-lactam antibiotictreatment for invasive Streptococcus pyogenes infection","volume":"18","author":"Zimbelman","year":"1999","journal-title":"Pediatr Infect Dis. J."},{"key":"B128","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.47.1.91","article-title":"The antigenic complex of streptococcus haemolyticus: I","volume":"47","author":"Lancefield","year":"1928","journal-title":"J Exp Med."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1084\/jem.167.3.1114","article-title":"The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci","volume":"167","author":"Jones","year":"1988","journal-title":"J Exp Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.4049\/jimmunol.0903520","article-title":"Ezrin, maspin, peroxiredoxin 2, and heat shock protein 27: potential targets of a streptococcal-induced autoimmune response in psoriasis","volume":"184","author":"Besgen","year":"2010","journal-title":"J Immunol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/jama.1969.03150190037007","article-title":"Rheumatic fever following streptococcal vaccination. Report of three cases","volume":"207","author":"Massell","year":"1969","journal-title":"JAMA"},{"key":"B132","first-page":"993","article-title":"Current approaches to group a streptococcal vaccine development","volume-title":"Streptococcus pyogenes: Basic Biology to Clinical Manifestations","author":"Dale","year":"2016"},{"key":"B133","first-page":"931","article-title":"Laboratory diagnosis of Streptococcus pyogenes (group A streptococci)","volume-title":"Streptococcus pyogenes: Basic Biology to Clinical Manifestations","author":"Spellerberg","year":"2016"},{"key":"B134","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/00006454-200205000-00014","article-title":"Clinical use and interpretation of group A streptococcal antibody tests: a practical approach for the pediatrician or primary care physician","volume":"21","author":"Shet","year":"2002","journal-title":"Pediatr Infect Dis J."},{"key":"B135","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2165\/00066982-200106040-00012","article-title":"16S rRNA gene sequencing for bacterial pathogen identification in the clinical laboratory","volume":"6","author":"Patel","year":"2001","journal-title":"Mol Diagn."},{"key":"B136","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00403-005-0559-7","article-title":"Incidental detection of S. pyogenes-DNA in psoriatic skin by PCR","volume":"296","author":"Weisenseel","year":"2005","journal-title":"Arch Dermatol Res."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2019.00006\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T07:31:05Z","timestamp":1694590265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2019.00006\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":136,"alternative-id":["10.3389\/fmed.2019.00006"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2019.00006","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,29]]},"article-number":"6"}}